accountoncology and genetic diseases, with emphasis on microRNA (miRNA). Asuragen's current diagnostic product portfolio consists of Signature Genetic Testing and Oncology Testing products as well as industry leading controls and standards engineered using its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Asuragen Awarded More Than $3.8 Million in New NIH Small Business Grants
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account